Rituximab in refractory chronic inflammatory demyelinating polyradiculoneuropathy: report of four cases.
Division of Neuroscience, Department of Neurology, Institute of Experimental Neurology (INSPE), San Raffaele Scientific Institute, Via Olgettina 48, Milan, 20132, Italy. velardo.daniele@gmail.com.
Daniele
http://orcid.org/0000-0003-1837-2788
D
Velardo
Division of Neuroscience, Department of Neurology, Institute of Experimental Neurology (INSPE), San Raffaele Scientific Institute, Via Olgettina 48, Milan, 20132, Italy.
Nilo
N
Riva
Division of Neuroscience, Department of Neurophysiology, Institute of Experimental Neurology (INSPE), San Raffaele Scientific Institute, Via Olgettina 48, Milan, 20132, Italy.
Ubaldo
U
Del Carro
Division of Neuroscience, Department of Neurophysiology, Institute of Experimental Neurology (INSPE), San Raffaele Scientific Institute, Via Olgettina 48, Milan, 20132, Italy.
Francesca
F
Bianchi
Division of Neuroscience, Department of Neurology, Institute of Experimental Neurology (INSPE), San Raffaele Scientific Institute, Via Olgettina 48, Milan, 20132, Italy.
Giancarlo
G
Comi
Division of Neuroscience, Department of Neurology, Institute of Experimental Neurology (INSPE), San Raffaele Scientific Institute, Via Olgettina 48, Milan, 20132, Italy.
Raffaella
R
Fazio
D000293:Adolescent; D000328:Adult; D000368:Aged; D006801:Humans; D007155:Immunologic Factors / Q000627:therapeutic use*; D008297:Male; D020277:Polyradiculoneuropathy, Chronic Inflammatory Demyelinating / Q000188:drug therapy*; D000069283:Rituximab / Q000627:therapeutic use*; D016896:Treatment Outcome
D007155:Immunologic Factors; D000069283:Rituximab